Item 8.01. Other Events.
On
Forward-Looking Statements
This Current Report on Form 8-K includes forward-looking statements based upon 9
Meters' current expectations. Forward-looking statements include, but are not
limited to, statements that express our intentions, beliefs, expectations,
strategies, predictions, anticipated milestones, and any other statements
relating to our future activities or other future events or conditions. These
statements are based on current expectations, estimates and projections about
our business based, in part, on assumptions made by management. Actual results
and the timing of events could differ materially from those anticipated in such
forward-looking statements as a result of various risks and uncertainties, which
include, without limitation: our ability to raise additional money to fund our
operations for at least the next 12 months as a going concern and the need to
raise additional capital to advance our product candidates and preclinical
programs, including in light of current stock market conditions; risks related
to our ability to successfully implement our strategic plans, including reliance
on our lead product candidate; uncertainties associated with the clinical
development and regulatory approval of product candidates, including in light of
our recent and ongoing FDA communications; uncertainties in obtaining successful
clinical results for product candidates and unexpected costs that may result
therefrom; risks related to the failure to realize any value from product
candidates and preclinical programs being developed and anticipated to be
developed in light of inherent risks and difficulties involved in successfully
bringing product candidates to market; intellectual property risks; the impact
of COVID-19 on our operations, enrollment in and timing of clinical trials;
reliance on collaborators; reliance on research and development partners; and
risks related to cybersecurity and data privacy. These and other risks and
uncertainties are more fully described in periodic filings with the
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description Exhibit 99.19 Meters Biopharma, Inc. Corporate Presentation. Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source